Literature DB >> 30742221

Primary Topography-Guided LASIK: Refractive, Visual, and Subjective Quality of Vision Outcomes for Astigmatism ⩾2.00 Diopters.

Avi Wallerstein, Marilou Caron-Cantin, Mathieu Gauvin, Eser Adiguzel, Mark Cohen.   

Abstract

PURPOSE: To evaluate the outcomes of primary topography-guided laser in situ keratomileusis (LASIK) in eyes with subjective refractive astigmatism of 2.00 diopters (D) or greater.
METHODS: This was a prospective study in consecutive eyes with cylinder of 2.00 D or greater that had LASIK using the Alcon WaveLight EX500 excimer laser and T-CAT/Contoura software (Alcon Laboratories, Inc., Fort Worth, TX). The accuracy, efficacy, safety, cylinder vector analysis, higher order aberrations, and patients' subjective quality of vision were assessed. Eyes with naturally occurring topographic irregular astigmatism were not excluded.
RESULTS: The mean cylinder was -2.55 D preoperatively and -0.34 D postoperatively; 81% and 95% of eyes were within ±0.50 and ±0.75 D of intended cylinder after LASIK, respectively. The correction index and index of success were 1.00 and 0.13, respectively. The efficacy and safety indexes were 0.98 and 1.04, respectively. The preoperative corneal topography irregularity index, anterior corneal higher order aberrations, and refractive astigmatism magnitude were mildly correlated to postoperative residual astigmatism. Mean ocular and corneal coma were not increased postoperatively. Patients had significant improvements after LASIK in both subjective uncorrected quality of vision and night vision disturbances compared to spectacle- and contact lens-corrected vision before LASIK.
CONCLUSIONS: Topography-guided ablation using the Alcon WaveLight EX500 excimer laser and T-CAT/Contoura software results in excellent accuracy, efficacy, and safety, with improved postoperative subjective quality of vision and reduced night vision disturbances in virgin eyes with refractive astigmatism of 2.00 D or greater, including eyes with topographic naturally occurring irregular astigmatism. [J Refract Surg. 2019;35(2):78-86.]. Copyright 2019, SLACK Incorporated.

Entities:  

Mesh:

Year:  2019        PMID: 30742221     DOI: 10.3928/1081597X-20181210-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

1.  Clinical results of topography-guided laser-assisted in situ keratomileusis using the anterior corneal astigmatism axis and manifest refractive astigmatism axis.

Authors:  Chunlei Liu; Tian Luo; Xuejun Fang; Ming Hu; Yun Su; Jing Li; Yan Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-27       Impact factor: 3.535

2.  Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis.

Authors:  Huang Zhang; Mingming Li; Zhimin Cen
Journal:  Comput Math Methods Med       Date:  2022-06-15       Impact factor: 2.809

3.  Refractive, visual, and subjective quality of vision outcomes for very high myopia LASIK from - 10.00 to - 13.50 diopters.

Authors:  Avi Wallerstein; Joseph Wai Keung Kam; Mathieu Gauvin; Eser Adiguzel; Mounir Bashour; Ananda Kalevar; Mark Cohen
Journal:  BMC Ophthalmol       Date:  2020-06-17       Impact factor: 2.209

4.  Hemidivisional vector planning to reduce and regularize irregular astigmatism by laser treatment.

Authors:  Noel Alpins; James K Y Ong; George Stamatelatos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-09       Impact factor: 3.535

5.  A multicenter study of the distribution pattern of posterior corneal astigmatism in Chinese myopic patients having corneal refractive surgery.

Authors:  Yijun Hu; Shanqing Zhu; Lu Xiong; Xuejun Fang; Jia Liu; Jin Zhou; Fangfang Li; Qingsong Zhang; Na Huang; Xiaohua Lei; Li Jiang; Zheng Wang
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

6.  Keratoconus Features on Corneal Higher-Order Aberration Ablation Maps: Proof-of-Concept of a New Diagnostic Modality.

Authors:  Avi Wallerstein; Mathieu Gauvin; Michael Mimouni; Louis Racine; Ali Salimi; Mark Cohen
Journal:  Clin Ophthalmol       Date:  2021-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.